Update in diffuse parenchymal lung disease 2011.
作者信息
Luckhardt Tracy R, Müller-Quernheim Joachim, Thannickal Victor J
机构信息
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Boulevard, Birmingham, AL 35294, USA.
出版信息
Am J Respir Crit Care Med. 2012 Jul 1;186(1):24-9. doi: 10.1164/rccm.201203-0509UP.
Abstract
摘要
相似文献
1
Update in diffuse parenchymal lung disease 2011.
Am J Respir Crit Care Med. 2012 Jul 1;186(1):24-9. doi: 10.1164/rccm.201203-0509UP.
2
Update in Interstitial Lung Disease 2014.
Am J Respir Crit Care Med. 2015 Sep 1;192(5):538-43. doi: 10.1164/rccm.201504-0768up.
3
Therapeutic Approach to Adult Fibrotic Lung Diseases.
Chest. 2016 Dec;150(6):1371-1386. doi: 10.1016/j.chest.2016.07.027. Epub 2016 Aug 10.
4
Spectrum of fibrosing diffuse parenchymal lung disease.
Mt Sinai J Med. 2009 Feb;76(1):2-23. doi: 10.1002/msj.20087.
5
Update in diffuse parenchymal lung diseases 2005.
Am J Respir Crit Care Med. 2006 May 15;173(10):1066-71. doi: 10.1164/rccm.2601011.
6
Update in diffuse parenchymal lung disease, 2013.
Am J Respir Crit Care Med. 2015 Feb 1;191(3):270-4. doi: 10.1164/rccm.201405-0856UP.
7
Adult interstitial lung diseases and their epidemiology.
Presse Med. 2020 Jun;49(2):104023. doi: 10.1016/j.lpm.2020.104023. Epub 2020 May 11.
8
The evolving pharmacotherapy of pulmonary fibrosis.
Expert Opin Pharmacother. 2013 Jan;14(1):79-89. doi: 10.1517/14656566.2013.758250.
9
Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
Respir Med. 2019 Jun;152:25-31. doi: 10.1016/j.rmed.2019.04.009. Epub 2019 Apr 22.
10
[Treatment in diffuse interstitial lung diseases].
Tuberk Toraks. 2005;53(2):190-9.
引用本文的文献
1
A clinical study to monitor prescription patterns, clinical outcomes, and adverse drug reactions among patients of various interstitial lung diseases attending respiratory medicine outpatient department at tertiary care hospital in Northern India.
Perspect Clin Res. 2024 Jul-Sep;15(3):141-146. doi: 10.4103/picr.picr_108_23. Epub 2024 Jul 4.
2
E-cigarette-/Vape-Associated Lung Injury as a Cause of Interstitial Lung Disease.
Cureus. 2024 Apr 13;16(4):e58199. doi: 10.7759/cureus.58199. eCollection 2024 Apr.
3
Spectrum of high-resolution computed tomography pattern in lungs in patients with connective tissue disorders.
Ann Afr Med. 2023 Jul-Sep;22(3):246-251. doi: 10.4103/aam.aam_157_21.
4
Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function.
Exp Ther Med. 2020 Aug;20(2):1285-1290. doi: 10.3892/etm.2020.8858. Epub 2020 Jun 10.
5
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2013 Jun 1;304(11):L709-21. doi: 10.1152/ajplung.00418.2012. Epub 2013 Apr 5.
本文引用的文献
1
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
Am J Respir Crit Care Med. 2012 May 15;185(10):1044-8. doi: 10.1164/rccm.201201-0006PP. Epub 2012 Apr 13.
2
Killer jeans and silicosis.
Am J Respir Crit Care Med. 2011 Dec 15;184(12):1322-4. doi: 10.1164/rccm.201108-1440ED.
3
Giant cell interstitial pneumonia: report of two cases with high titanium concentration in the lung.
Am J Respir Crit Care Med. 2011 Dec 1;184(11):1315-7. doi: 10.1164/ajrccm.184.11.1315a.
4
Regulatory T cells and lung fibrosis: a good cell gone bad.
Am J Respir Crit Care Med. 2011 Dec 1;184(11):1224-6. doi: 10.1164/rccm.201108-1572ED.
5
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment.
Respir Res. 2011 Oct 28;12(1):143. doi: 10.1186/1465-9921-12-143.
6
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
N Engl J Med. 2011 Sep 22;365(12):1079-87. doi: 10.1056/NEJMoa1103690.
7
Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.
Am J Respir Crit Care Med. 2011 Dec 15;184(12):1382-9. doi: 10.1164/rccm.201105-0840OC. Epub 2011 Sep 22.
8
Toward the blood-borne miRNome of human diseases.
Nat Methods. 2011 Sep 4;8(10):841-3. doi: 10.1038/nmeth.1682.
9
Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.
Am J Respir Crit Care Med. 2011 Dec 1;184(11):1270-81. doi: 10.1164/rccm.201103-0516OC. Epub 2011 Aug 25.
10
Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis.
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1153-63. doi: 10.1164/rccm.201106-1143OC. Epub 2011 Aug 18.
Zotero 插件